bupranolol has been researched along with amibegron in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blin, N; Camoin, L; Maigret, B; Strosberg, AD | 1 |
| Berlan, M; Carpéné, C; Galitzky, J; Lafontan, M; Portillo, M; Reverte, M | 1 |
| Balligand, JL; Donckier, JE; Gauthier, C; Heyndrickx, GR; Massart, PE; Van Mechelen, H | 1 |
| Erfanian, M; Gauthier, C; Heymann, MF; Langin, D; Laurent, K; Tavernier, G; Toumaniantz, G | 1 |
4 other study(ies) available for bupranolol and amibegron
| Article | Year |
|---|---|
Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; GTP-Binding Proteins; Humans; Models, Molecular; Protein Conformation; Receptors, Adrenergic, beta; Signal Transduction; Structure-Activity Relationship | 1993 |
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Topics: Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Cell Membrane; Dogs; Dose-Response Relationship, Drug; Epinephrine; Ethanolamines; Isoproterenol; Norepinephrine; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tetrahydronaphthalenes | 1993 |
Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Aorta; Atropine Derivatives; Blood Pressure; Bupranolol; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Hexamethonium; Hypertension, Renal; Lipolysis; Myocardial Contraction; Nadolol; Propanolamines; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes; Time Factors | 2001 |
beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blotting, Western; Bupranolol; Cyclic GMP; Depression, Chemical; Dioxoles; Electrocardiography; Humans; Mice; Mice, Transgenic; Models, Animal; Myocardial Contraction; Myocardium; Nadolol; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes | 2003 |